Leslie Serchuck

1.3k total citations
19 papers, 790 citations indexed

About

Leslie Serchuck is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Leslie Serchuck has authored 19 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 10 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Leslie Serchuck's work include HIV/AIDS Research and Interventions (15 papers), HIV Research and Treatment (10 papers) and HIV/AIDS drug development and treatment (7 papers). Leslie Serchuck is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), HIV Research and Treatment (10 papers) and HIV/AIDS drug development and treatment (7 papers). Leslie Serchuck collaborates with scholars based in United States, Puerto Rico and Brazil. Leslie Serchuck's co-authors include Lynne Mofenson, Russell Van Dyke, James M. Oleske, Cathy Wilfert, Rohan Hazra, Edward Handelsman, Brian L. Robbins, Lynnette Harris, Kathleen Malee and Edmund V. Capparelli and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and Journal of Allergy and Clinical Immunology.

In The Last Decade

Leslie Serchuck

19 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leslie Serchuck United States	16	508	361	213	144	80	19	790
Susan Bersoff‐Matcha United States	13	523 1.0×	305 0.8×	158 0.7×	168 1.2×	36 0.5×	21	1.1k
Gerrit‐Jan Weverling Netherlands	15	622 1.2×	395 1.1×	350 1.6×	74 0.5×	54 0.7×	20	1.1k
Ana González-Cordón Spain	17	459 0.9×	215 0.6×	237 1.1×	166 1.2×	35 0.4×	73	903
Philippe Lepage Belgium	12	292 0.6×	330 0.9×	188 0.9×	93 0.6×	37 0.5×	23	688
É. Rouveix France	15	464 0.9×	458 1.3×	184 0.9×	123 0.9×	51 0.6×	77	948
Emanuele Palomba Italy	13	408 0.8×	237 0.7×	216 1.0×	127 0.9×	34 0.4×	44	829
Andrea Kovacs United States	18	396 0.8×	385 1.1×	220 1.0×	100 0.7×	38 0.5×	28	776
Élisabeth Bouvet France	16	676 1.3×	486 1.3×	179 0.8×	99 0.7×	21 0.3×	36	982
Ann M. Labriola United States	10	523 1.0×	256 0.7×	294 1.4×	133 0.9×	119 1.5×	14	757
I. Grosch-Wörner Germany	9	411 0.8×	238 0.7×	245 1.2×	105 0.7×	34 0.4×	28	603

Countries citing papers authored by Leslie Serchuck

Since Specialization

Citations

This map shows the geographic impact of Leslie Serchuck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Serchuck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Serchuck more than expected).

Fields of papers citing papers by Leslie Serchuck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Serchuck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Serchuck. The network helps show where Leslie Serchuck may publish in the future.

Co-authorship network of co-authors of Leslie Serchuck

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Serchuck. A scholar is included among the top collaborators of Leslie Serchuck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Serchuck. Leslie Serchuck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Alzghoul, Bashar, Diana Barb, Mamoun Mardini, et al.. (2021). Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study. ERJ Open Research. 7(1). 754–2020. 9 indexed citations

Gerke, Alicia K., Xiaofeng Wang, Manuel L. Ribeiro Neto, et al.. (2019). Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 201(8). 955–964. 59 indexed citations

Llorente, Antolin M., Pim Brouwers, Robert M. Leighty, et al.. (2012). An Analysis of Select Emerging Executive Skills in Perinatally HIV-1-Infected Children. Applied Neuropsychology Child. 3(1). 10–25. 21 indexed citations

Hance, Laura Freimanis, et al.. (2010). Characteristics of HIV Infected Adolescents in Latin America: Results from the NISDI Pediatric Study. Journal of Tropical Pediatrics. 57(3). 165–172. 18 indexed citations

Serchuck, Leslie, Paige L. Williams, Sharon Nachman, et al.. (2010). Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected children as compared to controls living in HIV-affected households. AIDS Care. 22(5). 640–648. 9 indexed citations

Rudy, Bret J., John W. Sleasman, Bill G. Kapogiannis, et al.. (2009). Short-Cycle Therapy in Adolescents after Continuous Therapy with Established Viral Suppression: The Impact on Viral Load Suppression. AIDS Research and Human Retroviruses. 25(6). 555–561. 10 indexed citations

Chadwick, Ellen G., Jorge Pinto, Ram Yogev, et al.. (2009). Early Initiation of Lopinavir/Ritonavir in Infants Less Than 6 Weeks of Age. The Pediatric Infectious Disease Journal. 28(3). 215–219. 44 indexed citations

Mofenson, Lynne, Michael T. Brady, Kenneth L. Dominguez, et al.. (2009). Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.. PubMed. 58(RR-11). 1–166. 159 indexed citations

Chadwick, Ellen G., Edmund V. Capparelli, Ram Yogev, et al.. (2008). Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results. AIDS. 22(2). 249–255. 59 indexed citations

10.

Foster, Samuel B., Kenneth McIntosh, Bruce Thompson, et al.. (2008). Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study. Journal of Allergy and Clinical Immunology. 122(1). 159–165. 34 indexed citations

11.

Hazra, Rohan, Sonia Stoszek, Laura Freimanis Hance, et al.. (2008). Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries. International Journal of Epidemiology. 38(5). 1207–1214. 25 indexed citations

12.

Robbins, Brian L., Edmund V. Capparelli, Ellen G. Chadwick, et al.. (2008). Pharmacokinetics of High-Dose Lopinavir-Ritonavir with and without Saquinavir or Nonnucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus-Infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors. Antimicrobial Agents and Chemotherapy. 52(9). 3276–3283. 22 indexed citations

13.

Mellins, Claude A., Kathleen Malee, Lynnette Harris, et al.. (2008). Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women. AIDS Care. 20(8). 958–968. 105 indexed citations

14.

Flynn, Patricia M., Jack Rodman, Jane C. Lindsey, et al.. (2007). Intracellular Pharmacokinetics of Once versus Twice Daily Zidovudine and Lamivudine in Adolescents. Antimicrobial Agents and Chemotherapy. 51(10). 3516–3522. 20 indexed citations

15.

Mofenson, Lynne, James M. Oleske, Leslie Serchuck, Russell Van Dyke, & Cathy Wilfert. (2005). Treating Opportunistic Infections among HIV-Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. Clinical Infectious Diseases. 40(Supplement_1). S1–S84. 82 indexed citations

16.

Paul, Mary E., Manhattan Charurat, Leslie Serchuck, et al.. (2005). Predictors of immunologic long-term nonprogression in HIV-infected children: Implications for initiating therapy. Journal of Allergy and Clinical Immunology. 115(4). 848–855. 37 indexed citations

17.

Hershow, Ronald C., Edward Handelsman, Jane Pitt, et al.. (2005). Hepatitis C Virus Coinfection and HIV Load, CD4+ Cell Percentage, and Clinical Progression to AIDS or Death among HIV-Infected Women: Women and Infants Transmission Study. Clinical Infectious Diseases. 40(6). 859–867. 28 indexed citations

18.

Mofenson, Lynne, James M. Oleske, Leslie Serchuck, Russell Van Dyke, & Cathy Wilfert. (2004). Treating Opportunistic Infections Among HIV-Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. PsycEXTRA Dataset. 53(RR-14). 1–92. 24 indexed citations

19.

Jankelevich, Shirley, Brigitta U. Mueller, Crystal L. Mackall, et al.. (2001). Long‐term Virologic and Immunologic Responses in Human Immunodeficiency Virus Type 1–Infected Children Treated with Indinavir, Zidovudine, and Lamivudine. The Journal of Infectious Diseases. 183(7). 1116–1120. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact